Wilson's Disease clinical trials at UC Davis
1 research study open to eligible people
Showing trials for
VTX-801 in Adult Patients With Wilson's Disease
“Become involved in the GATEWAY Clinical Trial (Gene Therapy for Wilson's Disease)”
open to eligible people ages 18-65
The objectives of this clinical trial are to assess, for up to 5 years, the safety, tolerability and pharmacological activity of a single ascending doses of VTX-801, a gene therapy, administered intravenously (IV) to adult patients with Wilson's Disease prior to and following background WD therapy withdrawal.
Sacramento, California and other locations
Last updated: